Skip to main content
Cardiorenal Medicine logoLink to Cardiorenal Medicine
. 2015 Jun 27;5(4):237–245. doi: 10.1159/000433447

Influence of Chronic Kidney Disease on Physical Function and Quality of Life in Patients after Coronary Artery Bypass Grafting

Yueh-Ting Kuo a,b, Kuan-Ming Chiu c, Yuk-Ming Tsang d, Cheng-Ming Chiu b, Meng-Yueh Chien a,*
PMCID: PMC4662289  PMID: 26648940

Abstract

Aims

The purposes of this study were (1) to compare body composition, physical function, and quality of life (QOL) between patients after coronary artery bypass grafting (CABG) with and without chronic kidney disease (CKD) and (2) to analyze the factors associated with physical function and QOL domains in these patients.

Methods

Thirty male post-CABG patients with CKD and 30 matched controls were recruited. All subjects underwent dual-energy X-ray absorptiometry for body composition evaluation. Physical function tests included the grip strength test, 30-second chair stand test (30CST), and 6-min walk test (6MWT). Physical activity and QOL were assessed using the long form of the International Physical Activity Questionnaire and the World Health Organization Quality of Life Instrument (WHOQOL)-BREF, respectively.

Results

Post-CABG patients with CKD exhibited a lower arm lean mass and higher percent leg fat mass than those without CKD (p < 0.05). The patients with CKD also had lower 30CST scores, 6MWT distances, and QOL domain of social relationships scores than those without CKD after adjusting for covariates (p < 0.05). If NYHA class was considered in the model, NYHA class became the most important factor associated with 6MWT distances (β = −0.647, p < 0.001) and the QOL domains of psychological health (β = −0.285, p = 0.027) and environment (β = −0.406, p = 0.001).

Conclusion

Post-CABG patients with CKD had worse body composition, physical function, and QOL than those without CKD, and this might be associated with a worse NYHA class.

Key Words: Chronic kidney disease, Coronary artery bypass grafting, Body composition, Physical function, Quality of life

Introduction

Coronary artery disease (CAD) is the most prevalent fatal heart disease worldwide [1]. It has been reported that more than 500,000 coronary artery bypass grafting (CABG) surgeries are performed for CAD annually in the USA. Chronic kidney disease (CKD) is an important clinical comorbidity that increases the risk of death and myocardial infarction in patients with CAD [2]. It has been reported that CKD is present in 26% of patients undergoing CABG [3], and 31% of patients undergoing cardiac surgery have acute renal failure [4]. Preoperative and postoperative renal dysfunction has adverse effects on long-term mortality after CABG [5].

Although elective CABG surgery was reported to significantly improve patients' survival rates and quality of life (QOL), it is unknown whether CKD limits the beneficial effects of CABG procedures on patients' physical function and QOL. Many studies showed that patients undergoing dialysis and even mild-to-severe CKD experience decreases in physical function [6,7]. The low levels of physical function and physical activity that characterize patients with CKD in all stages and treatments are associated with poor clinical outcomes [8]. However, little is known about the influence of CKD on the physical function and QOL of patients after CABG. In previous studies, only Parikh et al. [9] reported that patients with severe CKD who underwent CABG showed improvement in the mental health domain but no improvement in the physical functioning domain of QOL, and may have had worse physical function than those without severe CKD. However, they did not perform physical function tests in post-CABG patients with CKD. Outcomes that focus on physical functioning could help determine the impact of diseases on the overall functioning of the patients.

Patients undergoing CABG now have good long-term survival rates. A better understanding of the physical function and QOL of patients with CKD undergoing CABG will be an important health issue. The main purposes of our study were (1) to compare the body composition, physical function, and QOL between post-CABG patients with CKD and those without CKD and (2) to analyze the factors associated with physical function and QOL domains in these patients.

Subjects and Methods

Patients (aged 40-75 years) who had undergone CABG surgery in the Department of Cardiovascular Surgery at the Far Eastern Memorial Hospital in New Taipei City, Taiwan, ROC, were invited to participate in this study. The exclusion criteria were: (1) history of heart transplantation surgery or >2 CABG procedures; (2) history of cancer; (3) claudication; (4) amputation or being nonambulatory, with or without the use of a walker or a cane, or (5) visual or hearing impairment, because either would have prevented the patients from completing the questionnaires and study measurements. Thirty male post-CABG patients with CKD (stages III-V) and 30 without CKD were included in this study. This trial was approved by our institutional review board (NCT01932008). Written informed consent was obtained from each participant before the investigation.

Definition of CKD

CKD was defined as an estimated glomerular filtration rate (eGFR) of <60 ml·× min−1·× 1.73 m−2 for ≥3 months. The eGFR was calculated using the Modification of Diet in Renal Disease Study formula: 186 × (serum creatinine)−1.154 × (age)−0.203 × 0.742 (if female) [10].

Outcome Measures

All subjects underwent dual-energy X-ray absorptiometry for body composition evaluation. Both lean body mass (LBM) and regional fat percentage were measured. Patients were asked to refrain from drinking more than 500 ml of fluid 1 h before their scans [11]. Physical function measurements included the grip strength test, 30-second chair stand test (30CST), and 6-min walk test (6MWT). The grip strength test and the 30CST measured the muscular strength of the upper and lower extremities, respectively. Participants were asked to squeeze the Jamar Hand Dynamometer (Jamar, Jackson, Mich., USA) with maximum strength using the dominant hand with the elbow extended in the standing position. For the 30CST, the number of full stands completed within 30 s was recorded using a 17-inch chair with the patient's arms crossed upon the chest [12]. The self-paced 6MWT was used to evaluate each participant's functional capacity, according to the American Thoracic Society guidelines [13].

Physical activity levels were evaluated using the self-administered long form of the International Physical Activity Questionnaire (IPAQ). The patients were categorized into 3 levels of physical activity: low, moderate, and high physical activity [14]. The World Health Organization Quality of Life Instrument (WHOQOL)-BREF (the adapted version for Taiwan) was used for QOL assessment [15]. The WHOQOL-BREF consists of frequency, intensity, capability, and evaluation in a 5-point response format. Each domain score ranges from 4 to 20.

Statistical Analyses

The Statistical Package for the Social Sciences (SPSS) for Windows version 17.0 (SPSS Inc., Chicago, Ill., USA) was used for the analyses. Data are presented as mean ± standard deviation or percentage. Student's t test and the χ2 test were used to examine the differences in baseline data and all measured variables between the two groups. Multiple linear regression analyses were used to evaluate the factors associated with physical function measurements and QOL domains after controlling for the covariates. The candidate variables included physical activity, age, comorbidity, postoperative time, group, body composition, and NYHA class. A p value <0.05 was considered statistically significant.

Results

Clinical Characteristics

The mean age of our participants was 62.3 ± 6.5 years, and the mean postoperative duration was approximately 4 years (table 1). There was no significant difference in demographic data between the two groups, except for the CKD-related parameters. However, all participants in the CABG group without CKD were in NYHA class I/II (100%), a percentage significantly higher than among those with CKD (53.3%; p < 0.001).

Table 1.

Comparison of demographic characteristics between the two groups

CKD Matched p value
Age, years 61.9 ± 6.6 62.6 ± 6.5 0.150
Postoperative time, months 46.6 ± 24.4 43.0 ± 25.1 0.478
Marital status 0.344
 Single 1 (3.3) 2 (6.7)
 Married 25 (83.3) 27 (90.0)
 Widowed/divorced 4 (13.3) 1 (3.3)
Educational level 0.446
 Below high school 18 (60.0) 15 (50.0)
 High school 10 (33.3) 9 (30.0)
 College graduate 2 (6.7) 6 (20.0)
Employment status 0.999
 Nonworking 19 (63.3) 19 (65.5)
 Working 11 (36.7) 10 (34.5)
Smoking 0.469
 Never 8 (26.7) 11 (36.7)
 Quit 18 (60.0) 13 (43.3)
 Current 4 (13.3) 6 (20.0)
Morbidity
 Hypertension 23 (76.7) 17 (56.7) 0.109
 Diabetes 19 (63.3) 13 (43.3) 0.180
 Hyperlipidemia 25 (83.3) 26 (86.7) 0.999
 Cardiovascular accidents 2 (6.7) 0 (0) 0.500
Comorbidities 0.999
 <3 19 (63.3) 20 (66.7)
 ≥3 11 (36.7) 10 (33.3)
NYHA class >0.001
 I/II 16 (53.3) 30 (100)
 III 14 (46.7) 0 (0)
CKD stage >0.001
 III 22 (73.3)
 IV 4 (13.3)
 V 4 (13.3)
Plasma profile
 Creatinine, mg/dl 2.84 ± 2.57 0.98 ± 0.13 >0.001
 eGFR, ml/min/1.73 m2 36.2 ± 14.6 84.3 ± 14.1 >0.001

Data are presented as mean ± standard deviation or n (%).

Physical Function and QOL

Patients with CKD had a significantly lower arm lean mass and higher percentage of leg fat than the matched controls (p < 0.05) (table 2). All physical function test results, including 30CST scores and 6MWT distances, were significantly better in the matched group than in the CKD group (p < 0.05). The percentage of high physical activity levels in the matched group was approximately twice that in the CKD group, but it did not reach statistical significance. Among the 4 QOL domains, the results were statistically significantly different in the social relationships domain (p = 0.005) and the environment domain (p = 0.011) between the two groups.

Table 2.

Anthropometric data, body composition, physical activity, physical function, and QOL in the two groups

CKD Matched p value
Anthropometrics
 Height, cm 164.57 ± 5.09 164.36 ± 5.09 0.757
 Weight, kg 76.09 ± 11.72 76.80 ± 12.83 0.524
 BMI 28.02 ± 3.51 28.35 ± 4.03 0.370
LBM, kg
 Arms 5.65 ± 1.06 6.04 ± 1.23 0.045
 Legs 15.81 ± 2.84 16.51 ± 2.70 0.081
 Trunk 23.49 ± 3.18 23.49 ± 3.15 0.995
 Total body 48.55 ± 6.86 49.78 ± 6.96 0.171
Percentage of fat mass
 Android 44.88 ± 7.07 43.78 ± 6.05 0.514
 Gynoid 32.63 ± 4.89 31.04 ± 4.38 0.165
 Android/gynoid fat ratio 139 ± 19 142 ± 19 0.485
 Arms 28.42 ± 4.58 27.63 ± 4.37 0.494
 Legs 25.63 ± 4.00 23.52 ± 3.49 0.042
 Trunk 38.49 ± 5.68 37.24 ± 5.47 0.357
Physical function
 Grip strength, kg 37.5 ± 8.3 40.7 ± 7.0 0.115
 30CST score 15.6 ± 4.8 20.0 ± 5.6 0.004
 6MWT distance, m 402.2 ± 78.3 489.1 ± 65.3 >0.001
 Total body fat, % 32.38 ± 4.43 30.82 ± 4.09 0.145
Physical activity
 Low 11 (36.7) 7 (23.3) 0.446
 Moderate 13 (43.3) 11 (36.7)
 High 6 (20.0) 12 (40.0)
QOL domain
 Physical health 12.27 ± 1.62 12.57 ± 1.44 0.427
 Psychological health 12.40 ± 1.49 13.24 ± 1.75 0.072
 Social relations 12.53 ± 2.28 14.17 ± 2.04 0.005
 Environment 13.85 ± 1.77 14.99 ± 1.64 0.011

Data are presented as mean ± standard deviation or n (%). BMI = Body mass index.

With regard to the factors related to physical function, grip strength was shown to be significantly associated with arm LBM (β = 0.561, p < 0.001) after controlling for covariates (table 3). Group was the most important factor associated with both 30CST (β = 0.356, p = 0.002) and 6MWT results (β = 0.469, p < 0.001) after controlling for covariates. If NYHA class was added to the model, this became the most important factor associated with 6MWT distances (β = −0.647, p < 0.001).

Table 3.

Stepwise multiple regression analysis of the factors associated with physical function

Dependent variables Adjusted R2, % Independent variables Unstandardized coefficients
β p value
estimate (SE) 95% CI
Model 1
Grip strength 30.3 arm LBM 0.004 (0.001) 0.002 to 0.005 0.561 <0.001
30CST 31.3 group 3.959 (l.23l) 1.494 to 6.425 0.356 0.002
age –0.304 (0.094) –0.491 to −0.116 –0.351 0.002
physical activity 2.021 (0.794) 0.431 to 3.612 0.282 0.014
6MWT 30.9 group 77.977 (18.578) 40.761 to 115.193 0.469 <0.001
physical activity 26.392 (11.890) 2.574 to 50.210 0.248 0.031

Model 2
Grip strength 40.1 arm LBM 0.004 (0.001) 0.002 to 0.005 0.540 <0.001
NYHA class –3.391 (1.044) –5.481 to −1.300 –0.328 0.002
30CST 31.3 group 3.959 (1.231) 1.494 to 6.425 0.356 0.002
age –0.304 (0.094) –0.491 to −0.116 –0.351 0.002
physical activity 2.021 (0.794) 0.431 to 3.612 0.282 0.014
6MWT 50.5 NYHA class –72.820 (10.531) –93.925 to −51.714 –0.647 <0.001
leg fat percentage –5.702 (2.005) –9.719 to −1.684 –0.264 0.006
age –3.292 (1.311) –5.919 to −0.664 –0.234 0.015

Model 1: adjusted for physical activity, age, comorbidity, postoperative time, group, arm LBM, and leg fat percentage. Model 2: model 1 + NYHA class.

With regard to the factors related to QOL domains (table 4), the physical domain of QOL was significantly associated with physical activity (β = 0.288, p = 0.016), postoperative time (β = 0.282, p = 0.018), and android fat (β = 0.272, p = 0.021) after controlling for covariates. Group was the most important factor associated with the domains of psychological health (β = 0.255, p = 0.049), social relationships (β = 0.359, p = 0.005), and environment (β = 0.311, p = 0.011) after controlling for covariates. If NYHA class was added to the model, this became the most important factor associated with the domains of psychological health (β = −0.285, p = 0.027) and environment (β = −0.406, p = 0.001).

Table 4.

Stepwise multiple regression analysis of the factors associated with QOL domains

Dependent variables Adjusted R2, % Independent variables Unstandardized coefficients
β p value
estimate (SE) 95% CI
Model 1
Physical health 22.8 physical activity 0.563 (0.227) 0.109 to 1.017 0.288 0.016
postoperative time 0.017 (0.007) 0.003 to 0.032 0.282 0.018
android fat 0.063 (0.027) 0.010 to 0.117 0.272 0.021
Psychological health 4.9 group 0.844 (0.420) 0.004 to 1.684 0.255 0.049
Social relations 11.4 group 1.633 (0.558) 0.517 to 2.750 0.359 0.005
Environment 16.5 group 1.104 (0.422) 0.258 to 1.949 0.311 0.011
comorbidity −1.114 (0.433) −2.000 to −0.228 −0.300 0.015

Model 2
Physical health 22.8 physical activity 0.563 (0.227) 0.109 to 1.017 0.288 0.016
postoperative time 0.017 (0.007) 0.003 to 0.032 0.282 0.018
android fat 0.063 (0.027) 0.01 to 0.117 0.272 0.021
Psychological health 6.5 NYHA class −0.631 (0.279) −1.189 to −0.073 −0.285 0.027
Social relations 11.4 group 1.633 (0.558) 0.517 to 2.75 0.359 0.005
Environment 26.3 NYHA class −0.966 (0.268) −1.502 to −0.43 −0.406 0.001
comorbidity −0.975 (0.418) −1.812 to −0.138 −0.262 0.023
postoperative time 0.017 (0.008) 0.001 to 0.033 0.233 0.042

Model 1: candidate variables: physical activity, age, comorbidity, postoperative time, group, and android fat. Model 2: model 1 + NYHA class.

Discussion

Our results revealed that coexisting CKD was an important factor associated with shorter 6MWT distances and poor QOL in post-CABG patients. However, when NYHA class was considered in the regression, it became the most important factor associated with 6MWT distances and QOL domains. These findings indicate that post-CABG patients with CKD have worse physical function and QOL satisfaction, and this might be associated with a worse NYHA class.

Effect of CKD on Body Composition, Physical Function, and QOL

A previous study reported that patients with CKD would have lower LBM because of a CKD-associated higher rate of muscle protein degradation [16]. Conversely, excess body fat was reported to be associated with inflammation and oxidative stress in patients with stage III-IV CKD [17]. Several studies have reported changes in whole body LBM and fat mass in CKD populations, but few addressed the regional LBM and fat mass of the extremities in this population. Our post-CABG patients with CKD showed reduced limb LBM and significantly higher leg fat percentages than those without CKD. Since 47% of our CKD participants reported with NYHA class III congestive heart failure (although they were medically stable and without edema of the lower extremities), some cardiac disease-related factors might account for this difference from the controls. Therefore, we further analyzed the leg fat percentages of the CKD subpopulation with NYHA class I-II heart failure as compared with their BMI-matched controls, excluding the CKD subjects with NYHA class III heart failure, and a difference no longer existed (p = 0.076). This result is in agreement with that of a previous report by Foster et al. [18]. The authors compared whole body and regional LBM and fat mass in children and adolescents with CKD and those without. They found significantly lower adjusted dual-energy X-ray absorptiometry Z-scores of leg LBM, but not of leg fat mass, in CKD stage IV-V patients compared with controls. It seemed that CKD influenced LBM much more, and congestive heart failure severity might have more impact on fat mass. Future studies are needed to provide more information regarding regional body composition in patients with cardiorenal syndrome.

Specifically, we found that a higher leg fat percentage was significantly and negatively associated with 6MWT distances after controlling for covariates in our post-CABG patients with CKD. Oreopoulos et al. [19] reported that a higher percentage of body fat was associated with a worse NYHA class. Although we cannot explain the causal relationship between leg fat percentages and 6MWT distances based on our cross-sectional design, it reminded us of the importance of maintaining a proper body composition to improve physical function and prevent secondary complications in post-CABG patients with CKD.

Numerous studies have shown significantly deteriorated physical function in dialysis patients compared with population norms; it was impaired even in the early stages of CKD [20]. Several potential causes or mechanisms, including anemia, an increase in protein catabolism, an inflammatory state, and a decrease in protein synthesis, have been proposed to contribute to decreased physical function [21]. By contrast, relatively few studies have addressed physical function in the predialysis period among patients with CKD [22]. Walker et al. [23] recently reported that non-dialysis CKD is associated with a high risk of frailty or diminished physical function. In our study, we found that post-CABG patients with non-dialysis CKD had lower physical function performance test scores than those without CKD. Brodin et al. [24] reported that with every 1 ml × min−1 × 1.73 m−2 drop in eGFR, the odds of failing the 30CST were 1.5 times higher. Our results are in agreement with their findings. Increasing evidence suggests that a regular evaluation of physical functioning could help determine the impact of CKD on the overall functioning of a patient; however, encouragement to regularly participate in physical activities has not been incorporated into routine care [8].

CKD in the early stages is often asymptomatic, and awareness is low [21]. However, it has been reported that patients with CKD have impaired health-related QOL even in the early stages. In our study, post-CABG patients with CKD had lower social relationships and environment domain scores than those without CKD. The social relationships domain includes 4 factors: personal relationships, social support, sexual activity, and respect. Therefore, it is important to assess the health-related QOL of patients with CKD, especially in the early stages, to improve our understanding of the patients' perspective and increase awareness of a possibly growing decline in the social relationships domain of QOL.

Our results revealed that coexisting CKD is significantly associated with shorter 6MWT distances and poor QOL in post-CABG patients. However, this might be due to a worse NYHA class. Actually, a previous study reported that a significant negative correlation was observed between eGFR and NYHA class [25]. In our study, 73.3% of the post-CABG patients with CKD were stage III, that is, their renal dysfunction was relatively mild. Therefore, it is speculated that the influence of CKD on physical function and QOL in cardiorenal syndrome patients is dependent on the severity of CKD and CAD. Both CKD and CAD have a negative impact on physical function and QOL; however, cardiac dysfunction led to physical functional deterioration more directly and obviously. When coexisting CKD becomes progressive, it might amplify the negative influence on physical function and QOL. Future studies are needed to further clarify this issue.

Limitations of the Study

Several limitations of our study must be acknowledged. First, this was a cross-sectional study; therefore, the causal relationship of physical activity, body composition, and physical function to QOL cannot be established. Second, based on the results of multiple regression analyses, NYHA class contributed to the findings in the CKD population. However, our control group was not matched by NYHA class. Third, our study lacked proteinuria and albuminuria data, and the periods between the assessments of the study parameters after CABG showed a wide range chronologically, with a mean of about 4 years and a standard deviation of 2 years. Therefore, we could neither detect nor estimate whether CKD or CAD had progressed and what its influence might have been on the study parameters. Forth, only elective and stable patients were recruited, and this may have produced biased overestimates of physical activity and physical function in the study sample. Therefore, the generalizability of our findings is limited.

Conclusion

Post-CABG patients with CKD had worse body composition, physical function, and QOL than their non-CKD counterparts. Coexisting CKD was an important factor associated with shorter 6MWT distances and poor QOL in post-CABG patients. Our results suggest the need for clinical experts to ensure regular physical activity in post-CABG patients with CKD to maintain or improve their physical function and QOL.

Disclosure Statement

The authors have no conflicts of interest to declare.

Acknowledgements

We would like to thank Prof. Ying-Tai Wu for practical assistance during the project, and the staff in the Department of Rehabilitation, the Department of Cardiovascular Surgery, and the Department of Radiology for their contributions to the research. This study was supported by grants (FEMH-2012-D-038) from the Far Eastern Memorial Hospital, Taiwan, ROC.

References

  • 1.Hawkes AL, Nowak M, Bidstrup B, Speare R. Outcomes of coronary artery bypass graft surgery. Vasc Health Risk Manag. 2006;2:477–484. doi: 10.2147/vhrm.2006.2.4.477. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Ix JH, Mercado N, Shlipak MG, Lemos PA, Boersma E, Lindeboom W, O'Neill WW, Wijns W, Serruys PW. Association of chronic kidney disease with clinical outcomes after coronary revascularization: the Arterial Revascularization Therapies Study (ARTS) Am Heart J. 2005;149:512–519. doi: 10.1016/j.ahj.2004.10.010. [DOI] [PubMed] [Google Scholar]
  • 3.Cooper WA, O'Brien SM, Thourani VH. Impact of renal dysfunction on outcomes of coronary artery bypass surgery: results from the Society of Thoracic Surgeons National Adult Cardiac Database. Circulation. 2006;113:1063–1070. doi: 10.1161/CIRCULATIONAHA.105.580084. [DOI] [PubMed] [Google Scholar]
  • 4.Chertow GM, Levy EM, Hammermeister KE, Grover F, Daley J. Independent association between acute renal failure and mortality following cardiac surgery. Am J Med. 1998;104:343–348. doi: 10.1016/s0002-9343(98)00058-8. [DOI] [PubMed] [Google Scholar]
  • 5.Orii K, Hioki M, Iedokoro Y, Shimizu K. Prognostic factors affecting clinical outcomes after coronary artery bypass surgery: analysis of patients with chronic kidney disease after 5.9 years of follow-up. J Nippon Med Sch. 2011;78:156–165. doi: 10.1272/jnms.78.156. [DOI] [PubMed] [Google Scholar]
  • 6.Perlman RL, Finkelstein FO, Liu L, Roys E, Kiser M, Eisele G, Burrows-Hudson S, Messana JM, Levin N, Rajagopalan S, Port FK, Wolfe RA, Saran R. Quality of life in chronic kidney disease (CKD): a cross-sectional analysis in the Renal Research Institute-CKD Study. Am J Kidney Dis. 2005;45:658–666. doi: 10.1053/j.ajkd.2004.12.021. [DOI] [PubMed] [Google Scholar]
  • 7.Mujais SK, Story K, Brouillette J, Takano T, Soroka S, Franek C, Mendelssohn D, Finkelstein FO. Health-related quality of life in CKD patients: correlates and evolution over time. Clin J Am Soc Nephrol. 2009;4:1293–1301. doi: 10.2215/CJN.05541008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Painter P, Roshanravn B. The association of physical activity and physical function with clinical outcomes in adults with chronic kidney disease. Curr Opin Nephrol Hypertens. 2013;22:615–623. doi: 10.1097/MNH.0b013e328365b43a. [DOI] [PubMed] [Google Scholar]
  • 9.Parikh CR, Coca SG, Smith GL, Caccarino V, Krumholz HM. Impact of chronic kidney disease on health-related quality-of-life improvement after coronary artery bypass surgery. Arch Intern Med. 2006;166:2014–2019. doi: 10.1001/archinte.166.18.2014. [DOI] [PubMed] [Google Scholar]
  • 10.Levey AS, Bosch JP, Lewis JB, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;130:461–470. doi: 10.7326/0003-4819-130-6-199903160-00002. [DOI] [PubMed] [Google Scholar]
  • 11.Heiss C, Naylor J, Bronco K, Myers B. A small food or fluid load has no effect on body composition measured by 3 different methods. Topics Clin Nutr. 2008;23:229–233. [Google Scholar]
  • 12.Tuna HD, Edeer AO, Malkoc M, Aksakoglu G. Effect of age and physical activity level on functional fitness in older adults. Eur Rev Aging Phys Act. 2009;6:99–106. [Google Scholar]
  • 13.American Thoracic Society ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111–117. doi: 10.1164/ajrccm.166.1.at1102. [DOI] [PubMed] [Google Scholar]
  • 14.Craig CL, Marshall AL, Sjöström M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, Oja P. International Physical Activity Questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35:1381–1395. doi: 10.1249/01.MSS.0000078924.61453.FB. [DOI] [PubMed] [Google Scholar]
  • 15.The World Health Organization Quality of Life Assessment (WHOQOL) development and general psychometric properties. Soc Sci Med. 1998;46:1569–1585. doi: 10.1016/s0277-9536(98)00009-4. [DOI] [PubMed] [Google Scholar]
  • 16.Adey D, Kumar R, McCarthy JT, Nair KS. Reduced synthesis of muscle proteins in chronic renal failure. Am J Physiol Endocrinol Metab. 2000;278:E219–E225. doi: 10.1152/ajpendo.2000.278.2.E219. [DOI] [PubMed] [Google Scholar]
  • 17.Ramos LF, Shintani A, Ikizler TA, Himmelfarb J. Oxidative stress and inflammation are associated with adiposity in moderate to severe CKD. J Am Soc Nephrol. 2008;19:593–599. doi: 10.1681/ASN.2007030355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Foster BJ, Kalkwarf HJ, Shults J, Zemel BS, Wetzsteon RJ, Thayu M, Foerster DL, Leonard MB. Association of chronic kidney disease with muscle deficits in children. J Am Soc Nephrol. 2011;22:377–386. doi: 10.1681/ASN.2010060603. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Oreopoulos A, Ezekowitz JA, McAlister FA, Kalantar-Zaden K, Fonarow GC, Norris CM, Hohnson J, Padwal RS. Association between direct measures of body composition and prognostic factors in chronic heart failure. Mayo Clin Proc. 2010;85:609–617. doi: 10.4065/mcp.2010.0103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Koufaki P, Kouidi E. Current best evidence recommendations on measurement and interpretation of physical function in patients with chronic kidney disease. Sports Med. 2010;40:1055–1074. doi: 10.2165/11536880-000000000-00000. [DOI] [PubMed] [Google Scholar]
  • 21.Hawkins MS, Sevick MA, Richardson CR, Fried LF, Arena VC, Kriska AM. Association between physical activity and kidney function: National Health and Nutrition Examination Survey. Med Sci Sports Exerc. 2011;43:1457–1464. doi: 10.1249/MSS.0b013e31820c0130. [DOI] [PubMed] [Google Scholar]
  • 22.Hiraki K, Yasuda T, Hotta C, Izawa KP, Morio Y, Watanabe S, Sakurada T, Shibagaki Y, Kimura K. Decreased physical function in pre-dialysis patients with chronic kidney disease. Clin Exp Nephrol. 2013;17:225–231. doi: 10.1007/s10157-012-0681-8. [DOI] [PubMed] [Google Scholar]
  • 23.Walker SR, Gill K, Macdonald K, Komenda P, Rigatto C, Sood MM, Bohm CJ, Storsley LJ, Tangri N. Association of frailty and physical function in patients with non-dialysis CKD: a systematic review. BMC Nephrol. 2013;14:228. doi: 10.1186/1471-2369-14-228. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Brodin E, Ljungman S, Sunnerhagen KS. Rising from a chair: a simple screening test for physical function in predialysis patients. Scand J Urol Nephrol. 2008;42:293–300. doi: 10.1080/00365590701797556. [DOI] [PubMed] [Google Scholar]
  • 25.Malyszko J, Bachorzewska-Gajewska H, Malyszko J, Levin-Iaina N, Iaina A, Dobrzycki S. Prevalence of chronic kidney disease and anemia in patients with coronary artery disease with normal serum creatinine undergoing percutaneous coronary interventions: relation to New York Heart Association class. Isr Med Assoc J. 2010;12:489–493. [PubMed] [Google Scholar]

Articles from Cardiorenal Medicine are provided here courtesy of Karger Publishers

RESOURCES